Aristo Bio-Tech and Lifescience Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

6.81

5.00

5.00

5.00

5.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

23.35

9.85

8.39

7.38

6.41

Loan funds

Secured loans

22.49

25.48

22.25

18.27

14.45

Unsecured loans

-

-

-

-

-

Total

52.65

40.33

35.63

30.64

25.85

Uses of funds

Fixed assets

Gross block

22.73

19.94

16.88

12.07

5.98

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

7.11

5.58

4.56

3.81

3.29

Net block

15.62

14.36

12.31

8.25

2.69

Capital work-in-progress

1.10

0.10

-

2.82

1.49

Investments

-

-

-

-

5.35

Net current assets

Current assets, loans & advances

83.11

62.54

69.10

76.84

81.17

Less : current liabilities & provisions

47.18

36.67

45.79

57.28

64.85

Total net current assets

35.93

25.87

23.31

19.57

16.33

Miscellaneous expenses not written

-

-

-

-

-

Total

52.65

40.33

35.63

30.64

25.85

Notes:

Book value of unquoted investments

-

-

-

-

5.35

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.72

0.65

0.06

-

-

Number of equity sharesoutstanding (Lacs)

68.08

49.95

49.95

49.95

49.95